$284.06
▼ -0.3% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 0
● 25
▼ 0
The Hidden Engine Behind Elevance Health Stock's Next Climb
The Real Risk Inside UnitedHealth Stock
Cigna Group (CI) Faces A Valuation Test, Is The Recent Pullback A Buying Opportunity?
Overview
52-week range
$240
$339
45% of range
Avg surprise (last 2)
+3.2%
Avg reaction (last 1)
-0.1%
0% positive
Latest IV / EM
54%
EM ±6.8% · $285 · Jul 31
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $6.26 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $6.98 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $7.20 | $7.14 | +0.8% | — | — | earnings |
| Fri May 2, 2025 | Mar/2025 | $6.74 | $6.39 | +5.5% | — | -0.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $2.63 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $5.45 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.97 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $4.74 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $4.92 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | BMO | $7.58 | $7.20 | +5.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $68.49B | — | $69.75B | $67.18B | $65.50B | — | $63.69B | $60.52B |
| Cost of revenue | $54.10B | — | $55.53B | $53.27B | $48.40B | — | $47.56B | $44.49B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $2.36B | — | $2.58B | $2.31B | $1.97B | — | $2.58B | $2.41B |
| Net income | $1.65B | — | — | — | $1.32B | — | — | — |
| EPS (diluted) | $6.26 | — | $6.98 | $5.71 | $4.85 | — | $2.63 | $5.45 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B | $7.55B | $5.89B | $6.79B |
| Inventory | $5.83B | $7.34B | $5.63B | $5.97B | $5.18B | $6.69B | $5.08B | $5.17B |
| Total current assets | $43.03B | $47.81B | $46.73B | $44.72B | $43.55B | $48.87B | $49.22B | $46.22B |
| Total assets | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B | $155.88B | $157.64B | $155.45B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B | $114.64B | $115.34B | $113.92B |
| Total equity | $42.21B | $41.71B | $41.80B | $40.21B | $40.23B | $41.03B | $42.09B | $41.33B |